Movik, E. (2008). Summary of published health economic studies of cetuximab as third line treatment for patients with metastatic colorectal cancer. Norwegian Knowledge Centre for the Health Services.
Chicago Style (17th ed.) CitationMovik, Espen. Summary of Published Health Economic Studies of Cetuximab as Third Line Treatment for Patients with Metastatic Colorectal Cancer. Oslo: Norwegian Knowledge Centre for the Health Services, 2008.
MLA (9th ed.) CitationMovik, Espen. Summary of Published Health Economic Studies of Cetuximab as Third Line Treatment for Patients with Metastatic Colorectal Cancer. Norwegian Knowledge Centre for the Health Services, 2008.
Warning: These citations may not always be 100% accurate.